magnifying glass
logo for Bausch & Lomb

Bausch & Lomb

Manufacturing · Canada · 19,600 Employees

Bausch & Lomb is a lobal eye health company that develops, manufactures and markets healthcare products. The company's products include over-the-counter products, dietary supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. They are based in Vaughan, Ontario, Canada.Read More

Contact

Who is Bausch & Lomb

Bausch & Lomb Headquarters

Headquarters

520 Applewood Cres, Vaughan, Ontario, L4K 4B4, Canada
Phone Number

Phone Number

(905) 695-7700
Bausch & Lomb Revenue

Revenue

$3.8B
Stock Symbol

Stock Symbol

BLCO
Industry

Industry

Bausch & Lomb's Social Media
Popular Searches

Bausch & Lomb Inc

Bausch & Lomb

Bausch & Lomb - Inc

Bausch & Lomb Corp

Bausch & Lomb LLC

SIC Code 51,512
NAICS Code 42,424
Ticker NYSE: BLCO

Top Competitors of Bausch & Lomb

Employess
46,000
revenue
$17.4B

1

Employess
113,000
revenue
$28.3B

3

Employess
1,259
revenue
$653.8M

5

Compare CEO

How does Joseph Papa compare against Competing Companies' CEOs?

Joseph Papa

Joseph Papa

CEO at Bausch & Lomb

Top 35%

CEO effectiveness to drive business results

Excellent
0%
Good
100%
Average
0%
Poor
0%
Very Bad
0%
CEO management style
Good
100%
Bad
0%

VS.

Joaquin Duato
Top 5%

CEO effectiveness to drive business results

Excellent
50%
Good
0%
Average
50%
Poor
0%
Very Bad
0%
CEO management style
Good
91%
Bad
8%
Select a different CEO to compare
Joaquin Duato

Joaquin Duato

CEO at Johnson & Johnson

Daniel McBride

Daniel McBride

CEO at CooperVision

Brenton Saunders

Brenton Saunders

CEO at Allergan

Bausch & Lomb Org Chart

PhonePhoneEmailEmail
Sam Eldessouky
Sam Eldessouky

Chief Financial Officer

PhonePhoneEmailEmail
Yehia Hashad
Yehia Hashad

Executive Vice President, Re...

PhonePhoneEmailEmail

PhonePhoneEmailEmail

Bausch & Lomb Email Formats

Bausch & Lomb uses at least 5 email formats with first.last (ex. John.Smith@bausch.com) being used 80.1% of the time

Bausch & Lomb Email FormatsPercentage

Get Verified Emails

View Email Formats for Bausch & Lomb

Bausch & Lomb Company Metrics

Company Insights
Employee Growth Rate
Bausch & Lomb Acquisitions & Subsidiaries
Acquisitions & Subsidiaries

Nov 05, 2021

Doctors Allergy Formula

Dec 24, 2012

Isolaz

Jun 13, 2012

Onpharma

May 06, 2012

CLRS Technology

Nov 20, 2009

PharmaSwiss

Bausch & Lomb

See More Acquisitions & Subsidiaries

Bausch & Lomb Tech Stack

Sched

By

Sched

fluct

By

Fluct

Kallidus

By

Kallidus

Dokeos

By

DOKEOS
See more technologies

Bausch & Lomb News & Media

Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2022 Financial Results on February 22

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, will release its fourth-quarter and full-year 2022 financial results on Wednesday, Feb. 22, 2023. Bausch + Lomb will host a conference call and live web cast at 8:00 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations

Bausch + Lomb affiliate bags KKR-backed AcuFocus

Bausch + Lomb, headquartered in Vaughan, Ontario, is a provider of eye care products. The post Bausch + Lomb affiliate bags KKR-backed AcuFocus appeared first on PE Hub.

Bausch + Lomb announces acquisition of AcuFocus - Healio

KOLOA, Hawaii — Bausch + Lomb has announced that an affiliate of the company has acquired AcuFocus.

Bausch + Lomb Acquires AcuFocus, Inc.

VAUGHAN, Ontario & IRVINE, Calif.--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, and AcuFocus, Inc. (“AcuFocus”), a privately held ophthalmic medical device company, today announced that an affiliate of Bausch + Lomb has acquired AcuFocus, pursuant to a merger transaction with the parent company of AcuFocus. AcuFocus has delivered breakthrough small aperture intraocular te

Bausch + Lomb Introduces Enhanced PreserVision® AREDS 2 Formula Mini Soft Gels with OCUSorb™

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. introduction of PreserVision® AREDS 2 Formula mini soft gels with OCUSorb™. This product is the only AREDS 2 eye vitamin with the OCUSorb formulation. Offering a proprietary composition of lutein and zeaxanthin, OCUSorb has been clinically shown to provide superior absorption of these
Read more news

Frequently Asked Questions regarding Bausch & Lomb

See more information about Bausch & Lomb

Working at Bausch & Lomb

eNPS iBausch & Lomb’s Employee Net Promoter Score (eNPS) is 2, as rated by 36 employees.
2eNPS Score
44% Promoters
14% Passives
42% Detractors

Trending Intent Signals iIntent topics are topics that prospects are actively searching for online.

Find out what Bausch & Lomb is actively searching across the web.

Topic

Signal Score

iSignal Score indicates how big the spike is compared to a company's historical baseline for consuming content.

Digital Transformation

100

3 Signals found

Signal Location
Asia
Date
1/30/23
Score
Audience
Bausch & Lomb Search Intents

Candidate Sourcing

86

5 Signals found

Signal Location
Europe
Date
1/30/23
Score
Audience
Bausch & Lomb Search Intents

Get Full Access

4.4/5 on G2 Crowd